December 12, 2024 23:56 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
UP teenager kills mother, lives with body for 5 days | At least six people including a child killed in Tamil Nadu hospital fire | Amid Atul Subhash row, SC says mere harassment is not enough to prove abetment to suicide | India's D Gukesh becomes youngest ever world champion in chess | Devendra Fadnavis meets PM Modi amid suspense over Maharashtra portfolio allocation | Congress wants to deviate the issue of Sonia Gandhi-George Soros link: JP Nadda | Bengaluru techie suicide: Atul Subhash's family demanded Rs. 10 lakh as dowry leading to my father's death, claims estranged wife | Syria rebels torch tomb of ousted president Bashar al-Assad's father | Donald Trump vows to eliminate birthright citizenship after taking charge | No alliance with Congress in Delhi polls: AAP chief Arvind Kejriwal

Study finds one in six people who stop antidepressants will experience discontinuation symptoms as a direct result

Jun 07, 2024, at 08:46 pm

For someone stopping taking antidepressants, the risk of experiencing one or more discontinuation symptoms (also called withdrawal symptoms), such as dizziness, headache, nausea, insomnia and irritability, due directly to stopping the medication is 15% (equivalent to one in six to seven people), according to a systematic review and meta-analysis published in The Lancet Psychiatry.

Antidepressants and opioids double the risk of falls and fractures in older people: Study

Jun 04, 2019, at 09:50 am

Sydney, June 4 (IBNS): Taking antidepressants or opioids more than doubles the risk of a fall and hip fracture in older people, according to a paper published today in Australian Prescriber. 

Depression and antidepressants are associated with an increased risk of venous thromboembolism: Study

Jul 25, 2018, at 06:40 pm

New Delhi, July 25 (IBNS): In the first review of its kind, new research has found that depression and the use of antidepressants are each associated with an increased risk of venous thromboembolism (VTE).